Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/11/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Ivan D. Horak MD

Wrong Dr. Ivan D. Horak MD?

Chief Scientific and Medical Offi...

Phone: (908) ***-****  
Email: i***@***.com
Local Address:  Bridgewater , New Jersey , United States
Symphogen Inc
116 Village Blvd. Ste. 200
Princeton , New Jersey 08540
United States

Company Description: With its pioneering antibody discovery and manufacturing technologies, Symphogen aims to create, develop, manufacture and commercialize target-specific recombinant...   more

Employment History

Board Memberships and Affiliations


  • MD
  • M.D.
114 Total References
Web References
Ivan ..., 12 May 2014 [cached]
Ivan Horak
Ivan Horak, M.D., CSO & CMO, Symphogen
Executive Management - symphogen, 11 Oct 2014 [cached]
Ivan D. Horak, MD, FACP Chief Scientific Officer and Medical Officer Prior to joining Symphogen, Dr. Horak served as President of Research and Development and Chief Scientific Officer of Enzon Pharmaceuticals Inc. Before that, Dr. Horak served as Chief Scientific Officer of Immunomedics, responsible for development of novel antibodies. Dr. Horak has authored over 70 peer-reviewed publications and several book chapters within the fields of hematology, oncology, and immunology and has served on the editorial boards of several scientific journals. Dr. Horak is board certified oncologist. He is Fellow of American College of Physicians and member of American Association for Cancer Research, American Society of Hematology, and American Society Clinical Oncology.
Today's News [cached]
"By combining our new CD20 antibody with our CD22 antibody, epratuzumab, it may be possible to significantly extend the survival of patients when compared with the use of either agent alone," Dr. Ivan Horak, Executive Vice President of Research and Development and Chief Scientific Officer of Immunomedics, remarked. * The Company reported several advances in cancer imaging products and early-stage cancer therapeutics, particularly for colorectal cancer, at the 50th Annual Meeting of the Society of Nuclear Medicine, including the following:
-- Improved therapeutic results were achieved using pretargeting methods involving the separation of antibody-based tumor targeting from the delivery of the therapeutic agent using bispecific antibodies that bind to both the tumor and the carrier of the therapeutic agent (usually a radiolabeled peptide).
..., 8 Aug 2005 [cached]
0001247903 HORAK IVAN D C/O IMMUNOMEDICS INC 300 AMERICAN ROAD MORRIS PLAINS NJ 07950 0 1 0 0 EVP of R&D & Chief Scien. Ofc.
Dr. Ivan D. ..., 28 Oct 2002 [cached]
Dr. Ivan D. Horak
In addition, one of our executive officers, Dr. Horak, is married to one of our employees.There are no other family relationships between directors, executive officers or other employees. Committees of the Board of Directors and Meetings Meeting Attendance.During fiscal 2002, the Board of Directors met six times.There are six standing committees of the Board of Directors which are described below.During fiscal 2002, no director attended fewer than 75% of the aggregate of (i) all Board of Directors meetings, and (ii) all meetings of committees on which he or she served.
Dr. Ivan D. Horak
Dr. Ivan D. Horak joined our company as Executive Vice President for Research and Development in May 2002.Prior to that time, Dr. Horak was employed by Pharmacia as a Vice President for Clinical Oncology, where he directed global development of oncology compounds from 1999 to 2002.From 1996 to 1999, Dr. Horak held a variety of clinical research positions at Janssen Research Foundation, a subsidiary of Johnson & Johnson, including Director, Research & Development.From 1986 to 1995, Dr. Horak was with the National Cancer Institute, where he studied the role of non-receptor tyrosine kinases in hematologic malignancies.Dr. Horak received his M.D. degree from the University of Komenius, Bratislava, Czechoslovakia.His work has resulted in over 40 publications related to cancer.He serves on the editorial board of Cancer Research.Dr. Horak is active in a number of scientific and medical societies, including the American Association for Cancer Research, American Society of Hematology, and American Society of Clinical Oncology.Dr. Horak is married to one of our employees.
Table of Contents
EXECUTIVE COMPENSATION Summary Compensation Table
Dr. Ivan D. Horak
Dr. Ivan D. Horak
Dr. Ivan D. Horak
In addition, our executive vice president, Dr. Ivan D. Horak, is married to one of our employees.
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.